{"id":"NCT00465985","sponsor":"Novartis","briefTitle":"Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome","officialTitle":"A Three-part,Multicenter Study,With a Randomized,Double-blind,Placebo Controlled,Withdrawal Design in Part II to Assess Efficacy,Safety,and Tolerability of ACZ885(Anti-interleukin-1beta Monoclonal Antibody)in Patients With Muckle-Wells Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-04","primaryCompletion":"2008-10","completion":null,"firstPosted":"2007-04-27","resultsPosted":"2011-02-11","lastUpdate":"2017-08-28"},"enrollment":35,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Muckle Wells Syndrome"],"interventions":[{"type":"DRUG","name":"ACZ885","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Part I, Part II-arm1, & Part III","type":"EXPERIMENTAL"},{"label":"Part II - arm 2","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to provide efficacy and safety data for ACZ885 (a fully human anti-interleukin-1beta (anti-IL-1beta) monoclonal antibody) administered as an injection subcutaneously (s.c.) in patients with Muckle-Wells Syndrome.\n\nPart I is an 8-week open-label, active treatment period to identify ACZ885 responders.\n\nPart II is a double-blind, placebo-controlled period to assess primarily the efficacy of ACZ885 compared to placebo.\n\nPart III is an open-label, active treatment period where patients will receive ACZ885 every 8 weeks after withdrawal or completion of Part II.","primaryOutcome":{"measure":"Percent of Participants With Disease Flare in Part II (After 24 Weeks of the Double-blind Part)","timeFrame":"32 weeks after study start","effectByArm":[{"arm":"ACZ885","deltaMin":0,"sd":null},{"arm":"Placebo","deltaMin":81.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":12,"countries":["United States","France","Germany","India","Spain","United Kingdom"]},"refs":{"pmids":["22152723","19494217"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":["Nasopharyngitis","Diarrhoea","Rhinitis","Influenza","Nausea"]}}